Early Prostate Cancer Antigen Expression in Predicting Presence of Prostate Cancer in Men With Histologically Negative Biopsies

Journal of Urology

Volumn 177, Issue 5, 2007, Pages 1736-1740

  Hansel, D E ^a   DeMarzo, A M ^a,b   Platz, E A ^a,b,c   Jadallah, S ^a   Hicks, J ^a   Epstein, J I ^a,b   Partin, A W ^a,b   Netto, G J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

adenocarcinoma; antigens; biological; neoplasm; prostate; tumor markers

Indexed keywords

NUCLEAR MATRIX PROTEIN; POLYCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER PATIENT; FALSE POSITIVE RESULT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN EXPRESSION; TISSUE SECTION;

ADENOCARCINOMA; AGED; ANTIGENS, NEOPLASM; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 34147116255     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.01.013     Document Type: Article

References (20)

1. Paul B., Dhir R., Landsittel D., Hitchens M.R., and Getzenberg R.H. Detection of prostate cancer with a blood-based assay for early prostate cancer antigen. Cancer Res 65 (2005) 4097
2. Dhir R., Vietmeier B., Arlotti J., Acquafondata M., Landsittel D., Masterson R., et al. Early identification of individuals with prostate cancer in negative biopsies. J Urol 171 (2004) 1419
3. Uetsuki H., Tsunemori H., Taoka R., Haba R., Ishikawa M., and Kakehi Y. Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate. J Urol 174 (2005) 514
4. Partin A.W., Getzenberg R.H., Carmichael M.J., Vindivich D., Yoo J., Epstein J.I., et al. Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res 53 (1993) 744
5. Brossner C., Madersbacher S., de Mare P., Ponholzer A., Al-Ali B., and Rauchenwald M. Follow-up of men obtaining a six-core versus a ten-core benign prostate biopsy 7 years previously. World J Urol 23 (2005) 419
6. Canto E.I., and Slawin K.M. Early management of prostate cancer: how to respond to an elevated PSA?. Annu Rev Med 53 (2002) 355
7. Lieberman R. Evidence-based medical perspectives: the evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progression of prostate cancer. Am J Ther 11 (2004) 501
8. Sindhwani P., and Wilson C.M. Prostatitis and serum prostate-specific antigen. Curr Urol Rep 6 (2005) 307
9. Satoh A., Matsumoto K., and Nakamura S. Is interval from an initial biopsy a significant predictor of prostate cancer at repeat biopsies?. Int J Urol 13 (2006) 224
10. Eggener S.E., Roehl K.A., and Catalona W.J. Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsy. J Urol 174 (2005) 500
11. Singh H., Canto E.I., Shariat S.F., Kadmon D., Miles B.J., Wheeler T.M., et al. Predictors of prostate cancer after initial negative systematic 12 core biopsy. J Urol 171 (2004) 1850
12. Hong Y.M., Lai F.C., Chon C.H., McNeal J.E., and Presti Jr. J.C. Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies. Urol Oncol 22 (2004) 7
13. Park S.J., Miyake H., Hara I., and Eto H. Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy. Int J Urol 10 (2003) 68
14. Mian B.M., Naya Y., Okihara K., Vakar-Lopez F., Troncoso P., and Babaian R.J. Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy. Urology 60 (2002) 836
15. Chan T.Y., and Epstein J.I. Follow-up of atypical prostate needle biopsies suspicious for cancer. Urology 53 (1999) 351
16. Epstein J.I., and Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol 175 (2006) 820
17. Cheville J.C., Reznicek M.J., and Bostwick D.G. The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Am J Clin Pathol 108 (1997) 633
18. Lakshmanan Y., Subong E.N., and Partin A.W. Differential nuclear matrix protein expression in prostate cancers: correlation with pathologic stage. J Urol 159 (1998) 1354
19. Barboro P., Rubagotti A., Boccardo F., Carnemolla B., Darrigo C., Patrone E., et al. Nuclear matrix protein expression in prostate cancer: possible prognostic and diagnostic applications. Anticancer Res 25 (2005) 3999
20. Jacobs T.W., Prioleau J.E., Stillman I.E., and Schnitt S.J. Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst 88 (1996) 1054